See more : Corporación Inmobiliaria Vesta, S.A.B. de C.V. (VTMX) Income Statement Analysis – Financial Results
Complete financial analysis of Unichem Laboratories Limited (UNICHEMLAB.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Unichem Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Vy Global Growth (VYGG) Income Statement Analysis – Financial Results
- HDHMS (443060.KS) Income Statement Analysis – Financial Results
- Middlebury National Corporation (MDVT) Income Statement Analysis – Financial Results
- Savola Group Company (2050.SR) Income Statement Analysis – Financial Results
- Western Superconducting Technologies Co., Ltd. (688122.SS) Income Statement Analysis – Financial Results
Unichem Laboratories Limited (UNICHEMLAB.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.unichemlabs.com
About Unichem Laboratories Limited
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company also manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.57B | 13.02B | 12.48B | 11.90B | 10.50B | 11.23B | 7.75B | 6.73B | 13.33B | 12.02B | 11.33B | 10.81B | 8.75B | 8.24B | 7.47B | 7.35B | 6.71B | 6.28B | 5.47B |
| Cost of Revenue | 13.40B | 5.70B | 4.41B | 4.01B | 4.10B | 4.67B | 3.72B | 2.69B | 4.70B | 4.53B | 3.95B | 4.04B | 3.15B | 3.15B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.17B | 7.32B | 8.07B | 7.89B | 6.40B | 6.56B | 4.03B | 4.04B | 8.63B | 7.49B | 7.38B | 6.77B | 5.60B | 5.09B | 7.47B | 7.35B | 6.71B | 6.28B | 5.47B |
| Gross Profit Ratio | 19.15% | 56.21% | 64.70% | 66.27% | 60.95% | 58.38% | 52.03% | 60.06% | 64.77% | 62.34% | 65.16% | 62.60% | 63.99% | 61.72% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 1.05B | 263.94M | 337.56M | 439.02M | 422.23M | 1.16B | 849.69M | 616.94M | 438.68M | 464.21M | 521.51M | 364.93M | 392.74M | 383.51M | 291.18M | 272.13M | 321.50M | 196.68M | 0.00 |
| General & Administrative | 432.93M | 333.22M | 324.77M | 364.23M | 493.35M | 341.09M | 236.42M | 146.78M | 295.79M | 238.07M | 209.01M | 941.00K | 979.07M | 876.90M | 5.47B | 5.66B | 5.53B | 5.16B | 4.59B |
| Selling & Marketing | 1.78B | 1.30B | 1.21B | 1.23B | 1.16B | 1.97B | 1.08B | 1.08B | 1.67B | 1.57B | 1.34B | 1.36B | 1.16B | 1.07B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.21B | 1.63B | 1.53B | 1.59B | 1.65B | 2.31B | 1.32B | 1.22B | 1.96B | 1.81B | 4.38B | 4.02B | 2.14B | 1.94B | 5.47B | 5.66B | 5.53B | 5.16B | 4.59B |
| Other Expenses | 0.00 | 3.45M | 5.15M | 50.64M | 7.22M | 26.16M | 15.85M | 15.30M | 62.48M | 68.55M | 72.37M | 53.39M | 26.32M | 43.44M | 0.00 | 0.00 | -53.47M | -12.56M | 133.87M |
| Operating Expenses | 6.73B | 9.21B | 8.18B | 7.81B | 7.71B | 7.92B | 5.81B | 4.88B | 7.38B | 6.89B | 6.06B | 5.41B | 4.66B | 3.88B | 5.93B | 6.06B | 5.96B | 5.39B | 4.67B |
| Cost & Expenses | 16.57B | 14.92B | 12.59B | 11.83B | 11.81B | 12.59B | 9.53B | 7.57B | 12.08B | 11.41B | 10.01B | 9.45B | 7.82B | 7.03B | 5.93B | 6.06B | 5.96B | 5.39B | 4.67B |
| Interest Income | 6.73M | 5.16M | 64.78M | 229.40M | 386.92M | 449.79M | 135.23M | 25.14M | 51.28M | 93.50M | 57.29M | 4.03M | 16.11M | 14.58M | 13.42M | 6.58M | 7.61M | 12.64M | 21.91M |
| Interest Expense | 226.61M | 162.52M | 50.21M | 44.00M | 71.21M | 70.40M | 77.96M | 31.67M | 27.27M | 29.58M | 31.29M | 32.90M | 40.78M | 23.92M | 23.83M | 25.55M | 21.95M | 24.87M | 38.24M |
| Depreciation & Amortization | 1.13B | 1.13B | 911.66M | 843.56M | 816.69M | 673.67M | 505.08M | 435.16M | 387.92M | 412.72M | 457.16M | 383.40M | 304.35M | 292.18M | 232.14M | 224.13M | 181.42M | 139.98M | 126.50M |
| EBITDA | 742.36M | -456.07M | 1.18B | 1.41B | 404.94M | 149.19M | -710.16M | -358.90M | 1.64B | 1.01B | 1.78B | 1.72B | 1.24B | 1.58B | 1.77B | 1.52B | 930.56M | 1.03B | 926.99M |
| EBITDA Ratio | 4.48% | -3.73% | 9.82% | 10.86% | 1.41% | 0.19% | -10.20% | -5.17% | 13.38% | 10.07% | 17.69% | 15.88% | 14.20% | 19.22% | 23.75% | 20.63% | 13.86% | 16.45% | 16.94% |
| Operating Income | 5.07M | -1.73B | -243.56M | -197.09M | -1.66B | -1.75B | -2.10B | -1.02B | 1.28B | 797.19M | 1.55B | 1.33B | 938.65M | 1.29B | 1.54B | 1.29B | 749.14M | 893.13M | 800.49M |
| Operating Income Ratio | 0.03% | -13.27% | -1.95% | -1.66% | -15.78% | -15.62% | -27.09% | -15.12% | 9.58% | 6.63% | 13.65% | 12.33% | 10.72% | 15.67% | 20.64% | 17.58% | 11.16% | 14.22% | 14.63% |
| Total Other Income/Expenses | -621.73M | -34.87M | -3.20B | 715.31M | 828.08M | 762.57M | 484.09M | 191.99M | 122.66M | -3.16B | 390.68M | 127.62M | 1.65M | 58.59M | -10.42M | -18.97M | -67.81M | -24.79M | 117.54M |
| Income Before Tax | -616.66M | -1.76B | 219.69M | 514.79M | -482.10M | -599.05M | -1.30B | -825.77M | 1.37B | 774.13M | 1.71B | 1.46B | 940.30M | 1.27B | 1.53B | 1.27B | 681.33M | 868.34M | 918.03M |
| Income Before Tax Ratio | -3.72% | -13.54% | 1.76% | 4.33% | -4.59% | -5.34% | -16.75% | -12.27% | 10.31% | 6.44% | 15.10% | 13.52% | 10.74% | 15.37% | 20.50% | 17.32% | 10.15% | 13.83% | 16.77% |
| Income Tax Expense | 88.08M | 258.65M | -110.93M | 171.55M | 119.72M | -343.48M | 33.42M | -118.54M | 292.99M | 21.32M | 430.04M | 328.47M | 227.72M | -316.82M | 304.30M | 192.00M | 172.50M | 165.85M | 115.00M |
| Net Income | -704.74M | -2.02B | 330.62M | 343.25M | -601.83M | -238.00M | 25.45B | 1.09B | 1.08B | 753.90M | 1.69B | 1.13B | 712.58M | 949.81M | 1.23B | 1.08B | 508.83M | 702.49M | 803.03M |
| Net Income Ratio | -4.25% | -15.53% | 2.65% | 2.88% | -5.73% | -2.12% | 328.49% | 16.15% | 8.11% | 6.27% | 14.94% | 10.48% | 8.14% | 11.53% | 16.43% | 14.71% | 7.58% | 11.19% | 14.67% |
| EPS | -10.01 | -28.72 | 4.70 | 4.88 | -8.55 | -3.38 | 280.59 | 11.96 | 11.90 | 8.31 | 18.69 | 12.52 | 7.89 | 10.53 | 13.66 | 11.99 | 5.70 | 7.79 | 9.04 |
| EPS Diluted | -10.01 | -28.72 | 4.68 | 4.88 | -8.55 | -3.38 | 280.41 | 11.96 | 11.88 | 8.29 | 18.63 | 12.48 | 7.86 | 10.47 | 13.58 | 11.98 | 5.70 | 7.79 | 9.02 |
| Weighted Avg Shares Out | 70.40M | 70.41M | 70.41M | 70.41M | 70.40M | 70.36M | 90.70M | 90.87M | 90.81M | 90.71M | 90.56M | 90.41M | 90.30M | 90.21M | 90.15M | 90.11M | 90.08M | 90.02M | 85.89M |
| Weighted Avg Shares Out (Dil) | 70.40M | 70.41M | 70.58M | 70.41M | 70.40M | 70.36M | 90.76M | 91.02M | 90.99M | 90.94M | 90.90M | 90.71M | 90.68M | 90.76M | 90.69M | 90.16M | 90.11M | 90.07M | 86.06M |
Source: https://incomestatements.info
Category: Stock Reports